Open AccessMETA-ANALYSIS ASSESSING THE IMPACT OF PRIOR HEART FAILURE AND CHRONIC KIDNEY DISEASE ON THE CARDIOVASCULAR EFFICACY OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS
Author(s) -
Dimitrios Patoulias,
Alexandra Katsimardou,
Ioanna Zografou,
Aristides Kefas,
Maria Toumpourleka,
Aristi Boulmpou,
George Kassimis,
Christodoulos Papadopoulos,
Michael Doumas
Publication year - 2022
Publication title -
journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.249
H-Index - 172
eISSN - 1473-5598
pISSN - 0263-6352
DOI - 10.1097/01.hjh.0000837320.01511.6f
Subject(s) - medicine , mace , heart failure , placebo , exenatide , kidney disease , lixisenatide , diabetes mellitus , adverse effect , type 2 diabetes , intensive care medicine , cardiology , myocardial infarction , endocrinology , percutaneous coronary intervention , pathology , alternative medicine